Genetic classification of colorectal cancer based on chromosomal loss and microsatellite instability predicts survival

Clinical Cancer Research

Volumn 8, Issue 7, 2002, Pages 2311-2322

  Choi, Sang Wook ^a   Lee, Kyung Jun ^a   Bae, Young An ^a   Min, Ki Ouk ^a   Kwon, Mi Seon ^a   Kim, Kyoung Mee ^a   Rhyu, Mun Gan ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER INVASION; CANCER SURVIVAL; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME 18Q; CHROMOSOME 3P; CHROMOSOME 4P; CHROMOSOME 5Q; CHROMOSOME 8P; CHROMOSOME 9P; CHROMOSOME LOSS; COLON CANCER; COLORECTAL CANCER; EARLY CANCER; FEMALE; GENE DELETION; GENE INSERTION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; RECTUM CANCER; TUMOR LOCALIZATION; ALLELE; CANCER STAGING; CHROMOSOME DELETION; CLASSIFICATION; COLORECTAL TUMOR; GENETICS; HUMAN CHROMOSOME; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE;

ALLELES; ANTINEOPLASTIC AGENTS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN; COLORECTAL NEOPLASMS; DNA, NEOPLASM; FEMALE; HUMAN; MALE; MICROSATELLITE REPEATS; MIDDLE AGE; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; SURVIVAL RATE; HUMANS; MIDDLE AGED;

ANTINEOPLASTIC AGENT; DNA; MICROSATELLITE DNA;

EID: 0035992401     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Are there several types of colorectal carcinomas? Correlations with genetic data
2. Loss of constitutional heterozygosity in human cancer
3. Tumor suppressor genes
4. Clues to the pathogenesis of familial colorectal cancer
5. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
6. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis
7. Microsatellite instability in cancer of the proximal colon
8. Tracking recurrent quantitative genomic alterations in colorectal cancer: Allelic losses in chromosome 4 correlate with tumor aggressiveness
9. Loss of heterozygosity in 8p is associated with microinvasion in colorectal carcinoma
10. Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers
11. Allelotype of colorectal carcinomas
12. Clinical and pathological associations with allelic loss in colorectal carcinoma
13. Survival and acquired genetic alterations in colorectal cancer
14. Allelic loss of chromosome 18q and prognosis in colorectal cancer
15. Microsatellite instability and the role of hMSH2 in sporadic colorectal cancer
16. Microsatellite instability in sporadic colon cancer patients with and without liver metastasis
17. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer
18. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer
19. Molecular predictors of survival after adjuvant chemotherapy for colorectal cancer
20. Prognostic implications of microsatellite genotypes in gastric carcinoma
21. Loss of heterozygosity at 3p23 is correlated with poor survival in patients with colorectal carcinoma
22. Identification and characterization of the familial adenomatous polyposis coli gene
23. Frequency of homozygous deletion at p16/CDKN2 in primary human tumors
24. Concordant p53 and DCC alterations and allelic losses on chromosomes 13q and 14q associated with liver metastases of colorectal carcinoma
25. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma
26. Hepatotoxicity associated with fluorouracil plus levamisole adjuvant therapy
27. Diagnostic primer sets for microsatellite instability optimized for a minimal amount of damaged DNA from colorectal tissue samples
28. The significance of allelic deletions and aneuploidy in colorectal carcinoma. Results of a 5-year follow-up study
29. Prognostic significance of allelic loss at chromosome 18q21 for stage II colorectal cancer
30. Evidence for two modes of allelic loss: Multifocal analysis on both early and advanced gastric carcinomas
31. Lessons from hereditary colorectal cancer
32. Genetic evidence for the multistep progression of mixed glandular-neuroendocrine gastric carcinomas